Advances in Signal Transduction-Based Drug Discovery (Technical Insights)

 


This research service outlines the key global developments in the field of signal transduction.

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

Table of Contents

Advances in Signal Transduction-Based Drug Discovery (Technical Insights), Executive SummaryScope and MethodologyScope and Segmentation of the Research ServiceResearch MethodologyRole of Signal Transduction in Drug DiscoveryDrug Discovery--The Changing ParadigmIndustry Scenario in Signal TransductionSignal Transduction-Based Drug Discovery--TechnologyAdvances in Signal Transduction-Based Drug Discovery (Technical Insights), Technical DevelopmentsTechnology PrimerMajor Families of Signal Transducing MoleculesRationale of Pathway Maps in Drug DiscoveryCell-Based Assay Approach to Drug DiscoveryAssessment of Enabling Technologies - Informatics or Cell-Based ApproachAn Informatics-Based Discovery Engine for GPCRs--IsraelDistinct Activated Checkpoint Therapy Platform for Drug Discovery--USABiological Illustration and Biopathway Modeling Software Tool--JapanSureFire Technology Assists in Cell-Based Screening--USAFunctional Protein Arrays Assist in Detecting Kinases--UKNanoprobes Can Identify Cells in Action--USAPlatform to Assist in Protein Kinase Analysis--USABiosensor Dye to Study Signaling in Live Cells--USAPathway Analysis Tool to Assist in Drug Discovery--IndiaCell-Based Screening Assisted with a Flexible Tag--USAProteomics Platform to Discover Protein Phosphorylation--USASignal Transduction Protein Array--First of its Kind--USAA High-Throughput Ion Channel Screening Service--UKCell-Based Technology Hastens Drug Discovery Process--USAA GPCR Internalization Assay--DenmarkAdvances in Signal Transduction-Based Drug Discovery (Technical Insights), Technology Adoption Factor AnalysisCompetitive LandscapeDriversChallengesIndustry InsightsAnalysis of the Druggable Genome and Explorable TargetsStakeholder AnalysisGeographic Trend AnalysisAdvances in Signal Transduction-Based Drug Discovery (Technical Insights), Patents and Database of Key Industry ParticipantsPatentsKinase PatentsG-protein Coupled Receptor PatentsIon-channel Receptor PatentsPatent AnalysisKey Industry Participants; GlossaryKey ParticipantsGlossary of Signaling MoleculesAdvances in Signal Transduction-Based Drug Discovery (Technical Insights), Decision Support DatabaseDatabase TablesGlobal R&D Expenditure for Biotechnology (2002-2012)Percent Government R&D Investment in Biotechnology (2002-2012)Global Pharmaceutical R&D Expenditure (2002-2012)Global Percentage Pharmaceutical R&D Expenditure (2002-2012)




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.